Dosage and administration
adults and children 12 years of age and over: apply a thin layer to affected area every 6 to 8 hours, not to exceed 3 applications in a 24 hour period children 12 years or younger: ask a doctor
adults and children 12 years of age and over: apply a thin layer to affected area every 6 to 8 hours, not to exceed 3 applications in a 24 hour period children 12 years or younger: ask a doctor
Lidocaine HCl 4%
Topical anesthetic
For external use only
Flammable: Keep away from fire or flame
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center right away.
children 12 years or younger:ask a doctor
Acrylates/C10-30 Acrylate Crosspolymer, Alcohol Denatured, Aloe Barbadensis Leaf Juice, Aminomethyl Propanol, C30-45 Alkyl Cetearyl Dimethicone Crosspolymer, Caprylyl Methicone, Cetearyl Alcohol, Ceteth-20 Phosphate, Dicetyl Phosphate, Dimethicone, Disodium EDTA, Ethylhexylglycerin, Glyceryl Stearate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Isohexadecane, Lavandula Angustifolia (Lavender) Oil, Methylparaben, Polysorbate 60, Steareth-2, Steareth-21, Water
CVS
Health
®
Compare to the active
ingredient in Aspercreme
®
Lidocaine with Lavender
Essential Oil*
MAXIMUM STRENGTH
Lidocaine concentration
without a prescription
†
Lidocaine
Pain Relief
Roll-On
LIDOCAINE HCI 4%
Lavender Essential Oil
With calming
lavender
aromatherapy
Actual Bottle
Size on
Side Panel
2.5 FL OZ
(73 mL)

Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 66902-057 | 66902-057-03 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2398c2ec-985e-6198-e063-6394a90ad8ef | ea1c78b3-7ae2-47b4-b45a-0c7fc623e592 | 2024-10-03 | Warnings | 2398c2ec-985e-6198-e063-6394a90ad8ef ea1c78b3-7ae2-47b4-b45a-0c7fc623e592 |
Adverse event summaries are temporarily unavailable. Other product information remains available.